BACKGROUND: information about adenosquamous carcinoma of the colon and rectum is scarce because of its extremely low incidence.
squamous-cell carcinoma (SCC) are uncommon, but clearly defined malignant tumors that occur within the colorectum. 1 Primary ASC and SCC of the colon and rectum are extremely rare clinical entities. Herxheimer 2 described the first case of a patient with an ASC of the cecum in 1907.
very few population-based data exist regarding these rare colorectal cancer (CrC) subtypes. most of the data come from individual case reports and a few small series from large institutions. the rarity of these tumors has made it a challenge to understand the biology of the disease. in addition, the clinicopathological behavior and optimal management of these rare tumors are not defined. However, in 2 small series, ASC and SCC of the colon and rectum have been reported to exhibit a poorer prognosis than invasive AC alone. 3, 4 With the use of data from the California Cancer registry (CCr), our study was intended to 1) describe the clinical and pathological characteristics of ASC, one of the rare CrCs; and 2) to determine overall survival and CrCspecific survival of ASC compared with AC of the colon and rectum.
MATERIALS AND METHODS

Study Population
the CCr is California's statewide population-based cancer surveillance system and is also part of the national Cancer institute's Surveillance, Epidemiology and End results (SEEr) program. Data were obtained from the CCr, which has the highest level of certification from the north American Association of Central Cancer registries. Since 1988, all cancer cases evaluated in California have been required by law to be reported to the CCr. Standardized data collection and quality control procedures have been in place since then. 5 Case reporting is estimated to be 99% for the entire state of California, with follow-up completion rates exceeding 95%. 5 International Classification of Diseases for Oncology codes based on the World Health organization's criteria were used for tumor location and histology. Cases were identified by using colorectal SEEr primary site code for colon and rectal cancers, excluding appendiceal carcinoma and anal cancer, as described previously. 6, 7 American Joint Committee on Cancer stage was derived as previously described. 7, 8 Using CCr data, we retrospectively evaluated cases of surgically treated cancer of the colon and rectum (excluding anus) from 1994 through 2004, with follow-up through 2008. CrC cases are included for 2 different types of histology including AC and ASC; other types of histologies and nonsurgically treated patients (chemotherapy/radiation only) were excluded from this study. Age, sex, race/ethnicity, socioeconomic status (SES), stage at presentation (tnm classification), tumor grade, and treatment (including surgical resection, chemotherapy, and radio therapy) were evaluated. SES was assigned on the basis of the patient's census block group (US Census) derived from their address at the time of initial diagnosis as reported in the medical record. this SES variable is an index that utilizes education, employment characteristics, median household income, proportion of the population living 200% below the Federal Poverty Level, median rent, and median housing value of census tract of residence for case and denominator population. A principal components analysis was used to identify quintiles of SES ranging from 1 (the lowest) to 5 (the highest). 7, 9 Cause of death was recorded according to International Classification of Diseases criteria in effect at the time of death.
10 the last date of follow-up was either the date of death or the last date of contact. in this study, CrC-specific mortality is defined as mortality caused by CrC as a primary pathology. 2 test for categorical variables. multivariable Cox proportional hazards regression analyses were used to estimate overall mortality and CrC-specific mortality, comparing cases with AC and ASC. Histological-specific survival analyses were conducted by the kaplan-meier method, and Cox regression models were performed using time from diagnosis until either 1) death from CrC or 2) a censoring event (end of study period, death from another cause, or loss to followup). All models were adjusted to other variables known to predict survival in CrC including age, sex, race, SES, tumor grade, tnm staging, and treatment. CrC-specific mortality and overall mortality were calculated from Cox Proportional Hazard ratios (Hr), using dummy variables to account for missing data. All statistical analyses were conducted with the use of Statistical Analysis System 9.2 statistical software (SAS institute, Cary, nC).
Statistical Analysis
Ethical Considerations
this study involved analyses of existing data from CCr database with no subject intervention. no identifiers were linked to subjects. this study was approved by the University of California, irvine institutional review Board under the category "exempt status" (institutional review Board 2010-7853).
RESULTS
A total of 111,263 AC and ASC colon and rectal cancer cases were identified during these 11 years; this includes 111,164 (99.91%) AC and 99 (0.09%) ASC. table 1 shows patient characteristics of the 2 groups. the ratio of females to males was almost 1:1 in the AC and ASC groups. the mean ages of AC and ASC patients were 69.5, and 67.0 years.
there was no significant difference in age group between groups. Comparison of the patients younger than 60 years old between the 2 groups showed that 21.8% of AC patients were younger than 60 years old, whereas 37.4% of ASC patients were younger than 60 years old. the majority of patients were white in the 2 groups (AC, 72.2% vs ASC, 69.7%). Comparing SES, no significant difference was observed between 2 groups. A smaller proportion of CrC patients were observed in the lower vs higher SES quintiles from 13.2% in the first quintile to 23.4% in the fifth quintile. table 2 shows pathological characteristics and treatments in all groups. ASC was significantly associated with higher distant metastasis rate (stage iv) at the time of operation (ASC, 36.56%; AC, 13.92%). Also, the ASC group was associated with a higher rate of poorly differentiated tumors (ASC, 65.96%; AC, 19.74%; p  0.001). the most common location of ASC and AC was the right and transverse colon (AC, 44.0% vs ASC, 56.3%). the most common procedure in the AC group was partial colectomy (43.6%), whereas subtotal colectomy (50.7%) was the most common procedure in the ASC group. Distribution of the treatments rendered is shown in table 2.
With the use of kaplan meier analyses for overall survival in this patient population, the median overall survival time was 2.33 times longer in the AC group (82.4 months) compared with the ASC group (35.3 months). Both 5-year overall and CrC-specific survival rates were significantly higher in the AC group compared with the ASC group (p  0.001) (Figs. 1 and 2 ). table 3 shows the overall and CrCspecific survival trends of these patient groups based on disease stage at the time of diagnosis (stage i--iii, without distant metastasis; stage iv, with distant metastasis) and overall survival regardless of disease stage (stage i--iv). in multivariable Cox proportional hazards regression analyses with adjustment for patient characteristics, SES, stage, and treatment with surgery, radiation therapy, and chemotherapy, ASC was independently associated with increased overall mortality (Hr, 1.67; 95% Ci, 1.33-2.10; p  0.001) and CrC-specific mortality (Hr, 1.69; 95% Ci, 1.29-2.23; p  0.001) compared with AC.
DISCUSSION
it has been reported that colorectal ASC makes up 0.05 to 0.20% 11 of colorectal malignancies. our population-based study, using data on a large number of CrC patients confirms the rarity of this tumor (ASC, 0.09%). the proportion of ASC in our study is in the previously reported range.
most studies have reported the occurrence of ASC in patients' sixth and seventh decade of life.
3 the mean age of patients with each type of tumor in our study was in the patient 's seventh decade (AC, 69.5 vs ASC, 67 years), and Survival distribution function ASC AC median age was 71 years in the AC group vs 69 years in the ASC group. With regard to sex, our study showed that the proportion of females and males were similar in both the ASC and AC groups. Although few previous studies reported the sex distribution in ASC, their results were different and limited cases were included in these studies. Similar to our study for ASC, a study by michelassi et al 12 showed that the proportion of males and females were identical, whereas Cagir et al 3 in a review of 145 ASC patients from national Cancer institute's SEEr reported male predominance (57%) of ASC. As for patient race, our results show that almost 70% of patients in both groups were white. in comparison with the race data of the California population over the past 20 years, white race represents the group with the greatest proportion of CrC compared to other races. Data on race in these rare tumors are limited; however, Cagir et al 3 found that whites comprised 84% of all patients. Although most early studies on ASC found the rectum (excluding the distal 8 cm) to be the most common site, 12, 13 our study shows that the most common location of ASC is in the proximal colon (similar to AC), and the least involved location is in the descending colon in both groups. Similarly, a study with a total of 56 ASC by Frizelle et al 4 showed that the right colon was the most common site of ASC. kontozoglou and moyana 14 identified the location of ASC in 29 cases, with 41% occurring in the proximal segment, 10% in the middle segment, and 49% in the distal segment of the colon. Cagir et al 3 found that ASC occurred most frequently in the distal segment, including the sigmoid colon, rectum, and anus (58%), followed by the proximal segment (28%) and middle segment (13%).
tumor stage and grade of differentiation at the time of diagnosis is associated with the prognosis of the patients. our study showed that, compared with AC, ASC was associated with a higher rate of advanced disease and higher rate of poor differentiation, and this may explain the higher overall and CrC-specific mortality observed for ASC in the univariate analyses. the pathological character of ASC is supported by many other studies. 11, 15, 16 However, our multivariate analyses adjusted for differences in stage and tumor grade, along with other clinically relevant factors -and the mortality differences remained.
We observed that patients in ASC group, after adjustment for age, sex, race, SES, location of tumor, stage of disease at diagnosis and treatment, had higher risk of both overall mortality (Hr, 1.67) and CrC-specific mortality (Hr, 1.69) compared with AC. our findings are consistent with the theory that squamous features in a colonic carcinoma impart a worse prognosis. 15 the survival curves in our study showed that both the 5-year overall survival rate and CrC-specific survival rate were higher in AC compared with ASC ( Figs. 1 and 2 ). Jemal et al 17 recently reported that the overall 5-year survival rates in the United States were 66% for colon cancer and 69% for rectal cancer. our study, over a longer time period, showed a 5-year survival rate of AC of 53.6%, and of ASC of 23.5%. in the current study, we observed that the 5-year survival rate was higher in the AC group for stage i--iii, stage iv, and stage i--iv. Similarly, Comer et al 18 found that the overall 5-year survival rate of ASC was 30% in comparison with 50% for AC. Previous studies reported similar survival rates for ASC compared with AC in early stages and lower survival rates in advanced stages.
3,4,14 Frizelle et al 4 found the prognosis of ASC to be similar to the prognosis of AC for stage i to ii nodenegative disease (Dukes A and B), and Cagir et al 3 found the survival rate for patients with ASC stages A and B1 to be similar to patients with comparably staged AC, whereas the patients with ASC staged B2 through D had significantly poorer survival than patients with comparably staged AC, supporting the reports of a poor prognosis associated with ASC.
there are limitations in our study. our results demonstrate the clinical characteristics of CrC in California, but they may not represent the patients in other areas. Because we did not include patients who were treated nonsurgically, our observations are limited to surgically resected patients. obviously, treatment modality and quality will affect outcomes; although we evaluated the treatment that had been used in these patients, treatment effects could not be fully evaluated and no conclusion on optimal therapeutic approach could be elucidated in our study because of data set limitations. Since ASC of colon and rectum is a rare disease, clinical trials are not available to help determine optimal management strategies. Some previous studies [19] [20] [21] have suggested that a combination of radiotherapy and chemotherapy directed at the squamous component might be useful; however, the roles of these therapies have not been proven. Also, it is important to note that cause-specific mortality, as assessed in population-based research, is subject to inaccuracy. However, others have shown that, in general, cause-specific and relative survival from population-based analyses are valid methodologic approaches. 22 Despite these limitations, this study provides a large sample size for evaluation of the outcomes of this rare colon and rectum carcinoma. 
CONCLUSION
ASC of the colon and rectum is observed in a small proportion of CrCs in the population. in comparison with AC, 1) ASC is comparable to AC in sex distribution, age, race, and SES, but presents with more advanced disease and with more poorly differentiated tumors; 2) ASC has lower 5-year survival rate in comparison with AC; and 3) ASC is independently associated with increased overall mortality and CrC-specific mortality and it should be considered as a poor prognostic factor in CrC patients.
